Waleed H. Hassanein, President & CEO at TransMedics Group, Inc. (TMDX), sold 14,850 shares at $134.69 ($2.0M) on 2024-05-15, disclosed to the SEC on 2024-05-17.
Scheduled sale ($2.0M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $133.42 | 300 | $40K | 2.0% |
| 2 | $134.69 | 2,100 | $283K | 14.1% |
| 3 | $135.54 | 5,481 | $743K | 36.9% |
| 4 | $135.54 | 5,481 | $743K | 36.9% |
| 5 | $136.26 | 744 | $101K | 5.0% |
| 6 | $136.26 | 744 |
| $101K |
| 5.0% |
| Total | $135.45 avg | 14,850 | $2.0M | 100% |
| Filing → |
| TMDX | SELL | 2024-10-17 | $2.1M | — | Filing → |
| TMDX | SELL | 2024-09-17 | $2.6M | — | Filing → |
| TMDX | SELL | 2024-08-23 | $7.8M | — | Filing → |